Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00557375 · ClinicalTrials.gov registry record

Brain Tumor Treatment Satisfaction Survey

A clinical trial of Brain Tumors, sponsored by Methodist Healthcare.

Completed
Registry status
105
Enrollment target
1
Study location

NCT00557375 is a study of Brain Tumors that has completed, run by Methodist Healthcare. The registered enrollment target is 105 participants, below the 6,332-participant average among 10 other Brain Tumors trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00557375, a study of Brain Tumors, has completed, sponsored by Methodist Healthcare.

COMPLETED
Registry status
105 participants
Enrollment target
1
Study location

Study Summary

Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.

Conditions Studied

Study Locations (1)

Tennessee

  • Methodist University Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2007-06-01
Est. Completion 2009-03-01

Sponsor

Methodist Healthcare

1 total trials

What the Registry Record Tells You About NCT00557375

The ClinicalTrials.gov registry entry for NCT00557375 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,332-participant average among 10 other Brain Tumors trials with a reported enrollment target (98% lower). The listed sponsor is Methodist Healthcare, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Tumors appearing as the primary indexed condition, and to 0 interventions.

NCT00557375 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00557375 about?

NCT00557375 is a clinical study titled "Brain Tumor Treatment Satisfaction Survey". Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state sin...

What is the current status of trial NCT00557375?

This trial is currently completed. The enrollment target is 105 participants. The study started on 2007-06-01. Estimated completion is 2009-03-01.

What conditions does trial NCT00557375 study?

This clinical trial studies the following conditions: Brain Tumors.

Who is sponsoring clinical trial NCT00557375?

This trial is sponsored by Methodist Healthcare, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00557375 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.